Evaluation of molecular residual disease in operable non-small cell lung cancer with gene fusions, MET exon skipping or de novo MET amplification
{{custom_author.name}}, {{article.zuoZheEn}}
Evaluation of molecular residual disease in operable non-small cell lung cancer with gene fusions, MET exon skipping or de novo MET amplification
[{{custom_ref.label}}] |
{{custom_citation.content}}
CrossRef
ADS
Pubmed
arXiv
Google scholar
|
/
〈 | 〉 |